최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국융합학회논문지 = Journal of the Korea Convergence Society, v.13 no.1, 2022년, pp.101 - 107
Tertomotide is a peptide vaccine developed for anti-cancer therapy. Since it has been found to ameliorate inflammatory symptoms in animal studies and clinical test, we investigated anti-inflammation activity of the tertomotide and the mechanism of action in monocyte in order to assess if tertomotide...
N. Relitti et al. (2020). Telomerase-based cancer therapeutics: A review on their clinical trials. Current Topics in Medicinal Chemistry, 20(6), 433-457.
Y. H. Park et al. (2019). GV1001 inhibits cell viability and induces apoptosis in castration-resistant prostate cancer cells through the AKT/NF-kappaB/VEGF pathway. Journal of Cancer. 10(25), 6269-6277.
V. E. Shaw et al. (2010). Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancer. Expert Review of Vaccines, 9(9), 1007-16.
J. Choi et al. (2015). The anti-inflammatory effect of GV1001 mediated by the down regulation of ENO1-induced pro-inflammatory cytokine production. Immune Network, 15(6), 291-303.
Y. J. Ko et al. (2015). The anti-inflammatory effect of human telomerase-derived peptide on P. gingivalis lipopolysaccharide-induced inflammatory cytokine production and its mechanism in human dental pulp cells. Mediators of Inflammation, 2015(385127), 1-8.
T. Y. Koo et al. (2014). Protective effect of peptide GV1001 against renal ischemia-reperfusion injury in mice. Transplant Proceedings. 46(4), 1117-22.
E. K. Lee et al. (2020). A telomerase-derived peptide vaccine inhibits laser-induced choroidal neovascularization in a rat model. Translational Research. 216, 30-42.
Y. M. Choi et al. (2020). A telomerase-derived peptide exerts an anti-hepatitis B virus effect via mitochondrial DNA stress-dependent type I interferon production. Frontiers in Immunology. 11(652), DOI : 10.3389/fimmu.2020.00652
J. Auwerx et al. (1991). The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia, 47(1), 22-31.
Y. Zhang et al. (2019). Therapeutic approaches in mitochondrial dysfunction, inflammation, and autophagy in uremic cachexia: role of aerobic exercise. Mediators in Inflammations, 2019(2879014), 1-11.
C. Madeddu, A. Maccio & G. Mantovani. (2012). Multitargeted treatment of cancer cachexia. Critical Reviews in Oncogenesis, 17(3), 305-14.
C. Staff et al. (2014). Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients. International Journal of Oncology, 45(3), 1293-303.
W. Chanput, J. J. Mes & H. J. Wichers. (2014). THP-1 cell line: an in vitro cell model for immune modulation approach. International Immuno pharmacology, 23(1), 37-45.
N. E. Annels et al. (2014). The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer. Cancer Immunololgy and Immunotherapy, 63(2), 175-83.
C. C. Hsu et al. (2013). Yuwen02f1 suppresses LPS-induced endotoxemia and adjuvant-induced arthritis primarily through blockade of ROS formation, NF-κB and MAPK activation. Biochemical Pharmacology. 85(3), 385-95.
K. L. Zapadka. (2017). Factors affecting the physical stability (aggregation) of peptide therapeutics. Interface focus. 7(6), 20170030.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.